Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China · Delayed Price · Currency is CNY 13.31
+0.14 (1.06%)
Sep 14, 2026, 3:04 PM CST
SHE:300181 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,205 | 3,041 | 2,578 | 1,942 | 1,805 | 1,457 |
Revenue Growth | 16.60% | 17.96% | 32.71% | 7.61% | 23.86% | 33.60% |
Gross Profit Gross Profit Growth | 1,963 | 1,863 | 1,559 | 1,326 | 1,271 | 1,037 |
Operating Income Operating Income Growth | 764.4 | 750.52 | 590.51 | 421.66 | 321.71 | 224.26 |
Net Income Net Income Growth | 633.36 | 631.93 | 507.77 | 382.94 | 273.01 | 179.41 |
Earnings Per Share EPS Growth | 0.91 | 0.91 | 0.73 | 0.55 | 0.45 | 0.29 |
EPS Growth | 7.94% | 24.66% | 32.73% | 22.22% | 55.17% | 98.77% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 2,368 | 2,043 | 1,729 | 1,640 | 1,319 |
Pharmaceutical Distribution Pharmaceutical Distribution Growth | 662.91 | 526.24 | 208.54 | 147.29 | 130.97 |
Unallocated Other Operations Unallocated Other Operations Growth | 9.77 | 8.95 | 5.2 | 18.23 | 7.26 |
Total Total Growth | 3,041 | 2,578 | 1,942 | 1,805 | 1,457 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 648.24 | 680.88 | 804.67 | 1,083 | 1,093 | 297.82 |
Total Debt Total Debt Growth | 781.69 | 692.01 | 429.59 | 222.25 | 173.13 | 206.67 |
Net Cash (Debt) Net Cash Growth | -133.45 | -11.13 | 375.08 | 860.73 | 919.77 | 91.15 |
Net Cash Growth | - | - | -56.42% | -6.42% | 909.09% | - |
Net Cash Per Share Net Cash Per Share Growth | -0.19 | -0.02 | 0.54 | 1.24 | 1.52 | 0.15 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 352.35 | 411.8 | 297.05 | 288.46 | 318.59 | 251.8 |
Capital Expenditures CapEx Growth | -212.17 | -287.14 | -262.89 | -131.71 | -178.03 | -147.95 |
Free Cash Flow Free Cash Flow Growth | 140.18 | 124.66 | 34.16 | 156.75 | 140.56 | 103.84 |
Free Cash Flow Growth | 149.37% | 264.94% | -78.21% | 11.52% | 35.35% | -53.08% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 61.23% | 61.25% | 60.48% | 68.27% | 70.38% | 71.16% |
Operating Margin | 23.85% | 24.68% | 22.91% | 21.71% | 17.82% | 15.39% |
Pretax Margin | 23.54% | 24.85% | 23.15% | 22.99% | 17.96% | 15.25% |
Profit Margin | 19.76% | 20.78% | 19.70% | 19.71% | 15.12% | 12.31% |
FCF Margin | 4.37% | 4.10% | 1.32% | 8.07% | 7.79% | 7.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.350 | 0.350 | 0.600 | 0.450 | 0.300 | 0.200 |
Dividend Per Share Growth | -41.67% | -41.67% | 33.33% | 50.00% | 50.00% | 100.00% |
Dividend Yield | 2.60% | 2.22% | 4.15% | 4.62% | 3.15% | 1.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 14.66 | 17.73 | 20.77 | 19.52 | 27.41 | 39.56 |
Forward PE | 12.80 | 15.65 | 16.58 | 16.53 | 24.08 | 61.41 |
P/FCF Ratio | 65.82 | 89.87 | 308.69 | 47.70 | 53.24 | 68.34 |
PS Ratio | 2.88 | 3.68 | 4.09 | 3.85 | 4.15 | 4.87 |